Cefaclor safety profile: a ten-year review
Clin Ther
.
1988:11 Suppl A:83-94.
Author
D L Hyslop
1
Affiliation
1
Chemotherapy Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
PMID:
3242837
No abstract available
MeSH terms
Adolescent
Adult
Aged
Bacterial Infections / drug therapy*
Cefaclor / adverse effects*
Cefaclor / therapeutic use
Cephalexin / analogs & derivatives*
Child
Child, Preschool
Humans
Infant
Infant, Newborn
Middle Aged
Substances
Cefaclor
Cephalexin